The January Approach
Building upon the finding that protein-based nano-formulations drive substantial improvements in the efficacy of known drugs, our goal is to create novel drugs with superior efficacy and reduced toxicity in hard-to-treat malignancies.
January Albumin-Drug Nanoparticles typically allow:
- Preferential tumor targeting over non-diseased tissue
- Significantly improved intravenous dosing vs. unmodified drug
- Potential for expanded clinical utility and ultimately wider potential treatment indications
11575 Sorrento Valley Rd., Suite 200
San Diego, CA 92121